
Do Utah and the UK Prove Clinical Oversight Is the Future of Medical Cannabis
18 ноя 2026 · 10:05
УправлениеОписание
As daily cannabis use climbs to roughly 1.2 million people in Great Britain (Forbes), retail pharmacy giant Boots is launching its SureLeaf online prescription service across roughly 1,800 UK locations to offer affordable medical cannabis flower and oil starting at £40—a mainstream breakthrough modeled directly on clinical pharmacy integration (MJBizDaily; The Telegraph). This rollout mirrors the clinical blueprint pioneered in Utah, where state law replaces traditional retail "budtenders" with licensed Pharmacy Medical Providers (PMPs) who review patient medical histories, screen for CYP-mediated drug interactions, and guide individualized dose titration (Pharmacy Times; Cannabis Industry Journal). Together, Utah's established framework and the UK's high-street expansion validate a crucial lesson underscored by pharmacy policy experts (Pharmacy Times): embedding licensed pharmacists into regulated cannabis distribution—rather than sidelining them as Canada did (Pharmacy Times)—legitimizes the plant as a safe, standardized therapeutic, protects vulnerable patients, and unlocks sustainable mainstream market growth.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
Комментарии
Комментариев пока нет — напишите первый.